Asuragen announce the launch of AmplideX PCR/CE DMPK Kit for myotonic dystrophy
Abacus dx would like to update you with the latest products from Asuragen.
22Jul
News
06Apr
Asuragen webinar: Is knowing SMN1 and SMN2 copy number enough?
Webinar Invitation:
Looking Beyond Copy Number:
Broad SMN1 and SMN2 profiling in under four hours with the AmplideX® PCR/CE SMN1/2 Plus Kit (RUO)
19Mar
Asuragen Launches SMN1/2 Plus Kit
Abacus dx is pleased to announce the launch of the latest assay from the Asuragen spinal muscular atrophy (SMA) portfolio – AmplideX® PCR/CE SMN1/2 Plus Kit*.
02May
Asuragen announce the launch of AmplideX® PCR/CE HTT kit for Huntington’s disease
Abacus dx would like to update you with the latest product from Asuragen.
28Sep
Asuragen: FragileX
The AmplideX® suite of products is designed to solve unmet testing needs in inherited genetic disorders. The technology overcame a 20-year challenge by reliably amplifying the FMR1 gene. This allowed researchers to gain a deeper understanding of fragile X syndrome, the most common known inherited cause of intellectual disability and autism.
27Sep
Asuragen: C9orf72
The AmplideX® C9orf72 Kit is a tool for the reliable amplification of the hexanucleotide CG repeat in the C9orf72 gene associated with amyotrophic lateral sclerosis and frontotemporal dementia.
20Aug
Asuragen announce the launch of AmplideX® PCR/CE SMN1 Kit for spinal muscular atrophy
Abacus dx would like to update you with the latest products from Asuragen.